Efficacy and Safety of Anlotinib in Patients with Advanced Non-Small Cell Lung Cancer: A Real-World Study
Qiuxia Zhong, Zhihua Liu Department of Radiation Oncology, The Affiliated Cancer Hospital of Nanchang University, Nanchang, Jiangxi, People’s Republic of ChinaCorrespondence: Zhihua LiuDepartment of Radiation Oncology, The Affiliated Cancer Hospital of Nanchang University, No. 519 East Bei...
Main Authors: | Zhong Q, Liu Z |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2021-05-01
|
Series: | Cancer Management and Research |
Subjects: | |
Online Access: | https://www.dovepress.com/efficacy-and-safety-of-anlotinib-in-patients-with-advanced-non-small-c-peer-reviewed-fulltext-article-CMAR |
Similar Items
-
The efficacy and safety of anlotinib treatment for advanced lung cancer
by: Shao L, et al.
Published: (2019-08-01) -
Clinical Investigation of the Efficacy and Safety of Anlotinib with Immunotherapy in Advanced Non-Small Cell Lung Cancer as Third-Line Therapy: A Retrospective Study
by: Yang S, et al.
Published: (2020-10-01) -
A Trial of the Safety and Efficacy of Chemotherapy Plus Anlotinib vs Chemotherapy Alone as Second- or Third-Line Salvage Treatment for Advanced Non-Small Cell Lung Cancer
by: Wang H, et al.
Published: (2020-05-01) -
Efficacy and Safety of Anlotinib for Patients with Advanced NSCLC Who Progressed After Standard Regimens and the Preliminary Analysis of an Efficacy Predictor
by: Cheng JD, et al.
Published: (2020-07-01) -
Efficacy and Safety of Anlotinib for Elderly Patients with Previously Treated Extensive-Stage SCLC and the Prognostic Significance of Common Adverse Reactions
by: Song PF, et al.
Published: (2020-11-01)